Ed. Geistlich Soehne AG fuer Chemische Industrie

Switzerland

Back to Profile

1-6 of 6 for Ed. Geistlich Soehne AG fuer Chemische Industrie Sort by
Query
Patent
Aggregations Reset Report
Jurisdiction
        World 2
        United States 2
        Canada 2
IPC Class
A61B 17/56 - Surgical instruments or methods for treatment of bones or jointsDevices specially adapted therefor 2
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans 2
A01K 43/04 - Grading eggs 1
A61K 31/54 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame 1
A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide 1
See more
Found results for  patents

1.

Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam

      
Application Number 12159875
Grant Number 07928102
Status In Force
Filing Date 2007-01-04
First Publication Date 2009-06-18
Grant Date 2011-04-19
Owner Ed. Geistlich Soehne AG fuer Chemische Industrie (Switzerland)
Inventor
  • Redmond, Paul H.
  • Pfirrmann, Rolf W.

Abstract

A composition formed by subjecting to ionizing radiation a combination containing a radiation-protective amount of PVP along with a solution, gel or adhesive including taurolidine, taurultam or a mixture thereof; or an aggregate including collagen-free crystals of taurolidine, taurultam or a mixture thereof.

IPC Classes  ?

  • A61K 31/54 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

2.

Method and device for synovial cell-charged collagen membrane or gel

      
Application Number 12091147
Grant Number 08293225
Status In Force
Filing Date 2006-10-23
First Publication Date 2008-11-13
Grant Date 2012-10-23
Owner Ed. Geistlich Soehne AG Fuer Chemische Industrie (Switzerland)
Inventor
  • Schaefer, Birgit
  • Schloesser, Lothar

Abstract

An implant for repair of a cartilaginous defect in a subject includes a collagen matrix charged with synovial cells. A method preparing an implant for repair of a cartilaginous defect in a subject includes obtaining a fluid containing synovial cells and charging the synovial cells to the matrix. A device for preparing a cell-charged implant includes a first chamber and a second chamber, the first and second chambers being separated by a membrane and a perforated filter. The membrane is adapted to collect cells from a cell-containing fluid introduced into the first chamber and the perforated filter is adapted to permit passage or diffusion of the fluid through the second chamber. A method for preparing a cell-charged implant utilizes the device.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor

3.

METHOD OF IMPROVING RENAL FUNCTION

      
Application Number US2007019262
Publication Number 2008/030413
Status In Force
Filing Date 2007-09-04
Publication Date 2008-03-13
Owner ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (Switzerland)
Inventor
  • Spector, Myron
  • Geistlich, Peter

Abstract

A method of improving renal function in a mammal suffering from, or at risk of developing, at least partial renal failure or renal dysfunction, includes administering to renal tissue of the mammal, a combination comprising a non-viral vector comprising a non-viral particulate carrier which carries a therapeutically effective amount of genetic material capable of expressing a renal function-enhancing Osteogenic Protein-1/Bone Morphogenic Protein-7 (OP-1/BMP-7) polypeptide in the renal tissue.

IPC Classes  ?

4.

IRRADIATED COMPOSITIONS AND TREATMENT OF CANCERS WITH RADIATION IN COMBINATION WITH TAUROLIDINE AND/OR TAURULTAM

      
Document Number 02636217
Status In Force
Filing Date 2007-01-04
Open to Public Date 2007-07-12
Grant Date 2014-02-25
Owner ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (Switzerland)
Inventor
  • Redmond, Paul H.
  • Pfirrmann, Rolf W.

Abstract

A composition formed by subjecting to ionizing radiation a combination containing a radiation-protective amount of PVP along with a solution, gel or adhesive including taurolidine, taurultam or a mixture thereof; or an aggregate including collagen-free crystals of taurolidine, taurultam or a mixture thereof.

IPC Classes  ?

  • A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
  • A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
  • A61P 35/00 - Antineoplastic agents

5.

METHOD OF REPAIRING MENISCAL TEARS USING A COLLAGEN MEMBRANE MATERIAL

      
Document Number 02621153
Status In Force
Filing Date 2006-09-01
Open to Public Date 2007-03-08
Grant Date 2016-10-18
Owner ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (Switzerland)
Inventor
  • Spector, Myron
  • Geistlich, Peter
  • Schloesser, Lothar
  • Jakob, Roland
  • Clemence, Jean-Francois

Abstract

A method of repairing a meniscal tear of a subject includes providing a sheet of collagen membrane material having on one side thereof a smooth barrier face which inhibits cell adhesion thereon and inhibits passage of cells therethrough. The sheet has a fibrous face opposite the smooth barrier face, the fibrous face allowing cell growth thereon. The collagen is predominantly collagen I. The sheet of collagen membrane material is fixed over a meniscal tear so that the fibrous face is oriented toward the meniscal tear.

IPC Classes  ?

  • A61B 17/56 - Surgical instruments or methods for treatment of bones or jointsDevices specially adapted therefor
  • A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans

6.

METHOD OF REPAIRING MENISCAL TEARS

      
Application Number US2006034329
Publication Number 2007/028078
Status In Force
Filing Date 2006-09-01
Publication Date 2007-03-08
Owner ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (Switzerland)
Inventor
  • Spector, Myron
  • Geistlich, Peter
  • Schloesser, Lothar
  • Jakob, Roland
  • Clemence, Jean-François

Abstract

A method of repairing a meniscal tear of a subject includes providing a sheet of collagen membrane material having on one side thereof a smooth barrier face which inhibits cell adhesion thereon and inhibits passage of cells therethrough. The sheet has a fibrous face opposite the smooth barrier face, the fibrous face allowing cell growth thereon. The collagen is predominantly collagen I. The sheet of collagen membrane material is fixed over a meniscal tear so that the fibrous face is oriented toward the meniscal tear.

IPC Classes  ?

  • A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
  • A61B 17/56 - Surgical instruments or methods for treatment of bones or jointsDevices specially adapted therefor